News

Creative Balloons closes €15 million growth financing and appoints Frank Gehres as CEO

Details

Creative Balloons, a specialist in medical technology, announces the successful completion of a €15 million growth financing, involving three leading German venture capitalists - Wellington Partners, MIG Fonds and Salvia. 

ONWARD Announces Publication in Nature Demonstrating Blood Pressure Stabilization in People with Spinal Cord Injury

Details

ONWARD announced the publication of a study in the journal, Nature, which found targeted electrical spinal cord stimulation stabilizes blood pressure in people with spinal cord injury (SCI). 

ONWARD Announces First Patient Enrolled in the Up-LIFT Pivotal Trial Assessing Safety and Effectiveness of ARC Therapy for Spinal Cord Injury

Details

ONWARD, formerly known as GTX Medical, today announced the first patient has been enrolled in a pivotal trial evaluating the Company’s ARC TherapyTM. 

  1. Quanta Receives FDA 510(k) Clearance for the SC+ Hemodialysis System Setting the Stage for US Market Launch
  2. PerkinElmer to Acquire Oxford Immunotec Global PLC
  3. CARISMA Therapeutics Completes Series B Funding for $47 Million to Advance Development of Novel CAR-Macrophage Immunotherapies
  4. Adrenomed Supervisory Board appoints Dr. Wolfgang Baiker as CEO
© Wellington Partners, 2021.